ArticleArthritis research & therapy2016

Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.

Jeffrey N Miner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.